<DOC>
	<DOCNO>NCT00234611</DOCNO>
	<brief_summary>Currently , majority heart failure patient qualify receive cardiac resynchronization therapy ( CRT ) device feel well implant . However , patient improve implant . Michigan Heart sponsor research study call LOCATE-Pilot help understand whether information echocardiogram , perform implant CRT device , improve patient ’ response CRT . This do evaluate heart ’ function echocardiogram , measure heart ’ response therapy . The study hypothesis response CRT may optimize guiding leave ventricular lead placement maximally delay , viable basal segment leave ventricle .</brief_summary>
	<brief_title>Localization CRT According Echocardiography : LOCATE-Pilot Study</brief_title>
	<detailed_description>CRT promise treatment modality medically-refractory New York Heart Association ( NYHA ) class III IV heart failure ( HF ) patient intraventricular conduction delay ( QRS &gt; 130 m ) . The randomized trial also suggest substantial minority patient benefit , either echocardiographically clinically , CRT . In MIRACLE trial , instance , 35 % patient clinically improve CRT . Objective reverse remodeling , typically define &gt; 15 % reduction end-systolic volume , occur approximately 60 % patient . Most echocardiographic study date report short- intermediate-term result . The objective LOCATE-Pilot study follow : 1 ) determine proportion patient undergo CRT CRT defibrillator ( CRT-D ) interpretable pulsed-wave tissue Doppler echocardiographic signal quantitate localize mechanical dyssynchrony ; 2 ) determine frequently LV lead successfully implanted delay basal segment ( area maximal delay ) ; 3 ) determine whether TDI guidance CRT improve proportion patient echocardiographic response treatment ( reverse remodel ) 6 month ; 4 ) determine whether TDI guidance CRT improve proportion patient clinical response treatment ( 6 min walk time , major clinical vascular event , Minnesota Living Heart Failure Quality Life score ) ; 5 ) confirm echocardiographic target LV lead implantation safe hamper efficiency electrophysiological laboratory ; 6 ) validate peak velocity delay ( PVD ) predictor CRT response use pulsed-wave Doppler tissue imaging . The LOCATE-pilot randomized , prospective study 60 patient undergoing implantation Medtronic market approve CRT system . All patient undergo comprehensive baseline echocardiographic study 6-segment model use quantify dyssynchrony pulsed-wave Doppler technique . Myocardial viability assess conventional 2D criterion nuclear perfusion data available . Patients randomize 1 2 group 30 patient per group intention-to-treat basis : 1 ) Control group : implanting physician knowledge baseline dyssynchrony assessment use current standard care LV lead implantation ; 2 ) Echo-Guided group : implanting physician full knowledge baseline echocardiographic study use dyssynchrony viability data guide final LV lead placement . For pilot study , patient follow 6 month repeat Echocardiogram 6 month . The primary endpoint study indexed end systolic volume decrease &gt; 15 % biplane Simpson ’ technique .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>male/female patient NYHA class III IV chronic heart failure symptom refractory standard therapy ( beta blocker either ACEI ARB stable dosage 1 month minimum duration 3 month therapy minimum ) patient sign date informed consent patient able receive pectoral device implant QRS &gt; = 130 m EF &lt; = 35 % followup Michigan Heart CHF clinic feasible patient understand protocol willing comply recent myocardial infarction ( &lt; 3 month ) recent surgical percutaneous revascularization ( &lt; 3months ) age &lt; 18 month permanent AF without AV junction ablation life expectancy 6 month woman childbearing potential willing able take birth control mechanical tricuspid valve prior orthotopic heart transplantation intermittent inotropic therapy inotropicdependent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>